{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T11:04:40Z","timestamp":1765191880267,"version":"3.46.0"},"reference-count":47,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["1598-RA"],"award-info":[{"award-number":["1598-RA"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The EQ-5D-Y (the youth version of EQ-5D) is widely used to assess children\u2019s health-related quality of life (HRQoL), yet its psychometric properties across administration modes remain insufficiently explored, particularly in paediatric oncology and rare diseases. Additionally, the broader impact of childhood illness on family caregivers (spillover effects) is underexamined. This study aims to evaluate the validity, reliability and responsiveness of the three-level version of EQ-5D-Y (EQ-5D-Y-3L) and the five-level version of EQ-5D-Y (EQ-5D-Y-5L) across different modes while also assessing the EQ-5D five-level version (EQ-5D-5L) and the new EQ Health and Well-being Short Version (EQ-HWB-9) in capturing spillover effects. Originally designed for social care interventions, the EQ-HWB-9 is expected to be applicable to caregivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This prospective observational study will recruit children aged 5\u201316 years with pneumonia, central nervous system (CNS) solid tumours or immune thrombocytopenic purpura (ITP) from three hospitals in China, along with their caregivers. A total of 360 dyads (patients and their caregivers) are planned for recruitment. Children will complete EQ-5D-Y-3L, EQ-5D-Y-5L and Paediatric Quality of Life Inventory (PedsQL) in self-complete (SC), interviewer-administered (IA) and proxy-reported modes by caregivers. Caregivers will complete EQ-5D-5L and EQ-HWB-9 to assess spillover effects. Data will be collected at baseline and follow-up (2\u20133 weeks). Primary outcomes include psychometric assessments (construct validity, reliability and responsiveness) of all the instruments. Secondary outcomes include HRQoL scores, ceiling effects and the correlation between EQ-5D-Y and PedsQL. A qualitative substudy will explore children\u2019s response interpretation and factors contributing to ceiling effects. Statistical analyses will include intraclass correlation coefficients for test\u2013retest reliability, analysis of variance for known-groups validity, effect sizes for responsiveness, regression for spillover effects and thematic analysis for qualitative data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from three ethics committees: the Guizhou Medical University (IRB:2024159), the Children\u2019s Hospital, Zhejiang University School of Medicine (IRB:2024-IRB-0158-P-01) and Guizhou Provincial People\u2019s Hospital (IRB:2024073). Written informed consent will be secured from caregivers, and assent will be obtained from children aged 8 years and older. Study findings will be disseminated through national\/international conferences and peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06873672\">NCT06873672<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-102509","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:30:41Z","timestamp":1750224641000},"page":"e102509","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of EuroQol instruments in paediatric patients and their caregivers in China: protocol for a prospective observational study"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06873672","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Xingju","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-4564","authenticated-orcid":false,"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Department of Medical Psychology and Psychotherapy, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Yang","sequence":"additional","affiliation":[{"name":"Health Services Management Department, Guizhou Medical University, Guiyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai","family":"Guannan","sequence":"additional","affiliation":[{"name":"Department of Child Health Care, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0178-7007","authenticated-orcid":false,"given":"Jiaxing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Busschbach","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"2025120803001968000_15.6.e102509.1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jval.2022.05.013","article-title":"Measurement Properties of the EQ-5D-Y: A Systematic Review","volume":"25","author":"Golicki","year":"2022","journal-title":"Value Health"},{"unstructured":"EuroQol Research Foundation . EQ-5D-Y-5L User Guide, 2024. Available: https:\/\/euroqol.org\/information-and-support\/documentation\/user-guides","key":"2025120803001968000_15.6.e102509.2"},{"key":"2025120803001968000_15.6.e102509.3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10198-018-1026-7","article-title":"A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients","volume":"20","author":"Wong","year":"2019","journal-title":"Eur J Health Econ"},{"key":"2025120803001968000_15.6.e102509.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-021-01889-4","article-title":"Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients","volume":"19","author":"Fitriana","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2025120803001968000_15.6.e102509.5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12955-020-01366-4","article-title":"EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents \u2013 a cross-sectional study","volume":"18","author":"\u00c5str\u00f6m","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2025120803001968000_15.6.e102509.6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10198-021-01307-y","article-title":"Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China","volume":"22","author":"Pei","year":"2021","journal-title":"Eur J Health Econ"},{"key":"2025120803001968000_15.6.e102509.7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10198-022-01435-z","article-title":"Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis","volume":"23","author":"Lin","year":"2022","journal-title":"Eur J Health Econ"},{"key":"2025120803001968000_15.6.e102509.8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10198-021-01309-w","article-title":"Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies","volume":"22","author":"Zhou","year":"2021","journal-title":"Eur J Health Econ"},{"key":"2025120803001968000_15.6.e102509.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-022-01996-w","article-title":"EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report","volume":"20","author":"Fitriana","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"2025120803001968000_15.6.e102509.10","article-title":"Performance of the EQ-5D-Y Interviewer Administered Version in Young Children","volume":"9","author":"Amien","year":"2022","journal-title":"Children (Basel)"},{"key":"2025120803001968000_15.6.e102509.11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/BRS.0000000000003116","article-title":"Responsiveness of EQ-5D Youth version 5-level (EQ-5D-5L-Y) and 3-level (EQ-5D-3L-Y) in Patients With Idiopathic Scoliosis","volume":"44","author":"Wong","year":"2019","journal-title":"Spine (Phila Pa 1986)"},{"key":"2025120803001968000_15.6.e102509.12","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-022-01938-6","article-title":"Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care","volume":"20","author":"Verstraete","year":"2022","journal-title":"Health Qual Life Outcomes"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.13","DOI":"10.1097\/00005650-199902000-00003"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.14","DOI":"10.1016\/S0140-6736(13)60222-6"},{"key":"2025120803001968000_15.6.e102509.15","first-page":"1012","article-title":"Comparative analysis of children\u2019s medical insurance system in Shanghai","volume":"31","author":"Wang","year":"2011","journal-title":"J Shanghai Jiaotong Univ (Med)"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.16","DOI":"10.1016\/j.prrv.2016.07.002"},{"key":"2025120803001968000_15.6.e102509.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-023-02100-6","article-title":"The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children","volume":"21","author":"Amien","year":"2023","journal-title":"Health Qual Life Outcomes"},{"key":"2025120803001968000_15.6.e102509.18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2025120803001968000_15.6.e102509.19","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191811420","article-title":"Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study","volume":"19","author":"Perez-Sousa","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025120803001968000_15.6.e102509.20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11136-013-0593-4","article-title":"Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference?","volume":"23","author":"Sagberg","year":"2014","journal-title":"Qual Life Res"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.21","DOI":"10.1002\/ajh.21616"},{"unstructured":"Orkin SH , Nathan DG , Ginsburg D , et al . Nathan and Oski\u2019s hematology of infancy and childhood. 8th edn. Philadelphia, PA: Saunders Elsevier, 2015.","key":"2025120803001968000_15.6.e102509.22"},{"key":"2025120803001968000_15.6.e102509.23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26405","article-title":"Patterns and influences in health\u2010related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort","volume":"64","author":"Flores","year":"2017","journal-title":"Pediatric Blood & Cancer"},{"key":"2025120803001968000_15.6.e102509.24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.2010.08322.x","article-title":"Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP)","volume":"151","author":"Sarpatwari","year":"2010","journal-title":"Br J Haematol"},{"key":"2025120803001968000_15.6.e102509.25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/09537104.2013.831065","article-title":"Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia","volume":"25","author":"Suvajdzic","year":"2014","journal-title":"Platelets"},{"key":"2025120803001968000_15.6.e102509.26","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-112378","article-title":"Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)","volume":"132","author":"Kruse","year":"2018","journal-title":"Blood"},{"key":"2025120803001968000_15.6.e102509.27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40273-023-01321-3","article-title":"Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force","volume":"42","author":"Henry","year":"2024","journal-title":"Pharmacoeconomics"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.28","DOI":"10.1007\/s40273-019-00768-7"},{"key":"2025120803001968000_15.6.e102509.29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10198-021-01306-z","article-title":"What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?","volume":"22","author":"Peasgood","year":"2021","journal-title":"Eur J Health Econ"},{"unstructured":"World Health Organization . Revised WHO classification and treatment of childhood pneumonia at health facilities: evidence summaries. Switzerland: WHO, 2014. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/137319\/9789241507813_eng.pdf?sequence=1","key":"2025120803001968000_15.6.e102509.30"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.31","DOI":"10.1200\/JCO.1993.11.8.1466"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.32","DOI":"10.1182\/bloodadvances.2019000966"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.33","DOI":"10.1007\/s11136-010-9648-y"},{"doi-asserted-by":"crossref","unstructured":"Kreimeier S , \u00c5str\u00f6m M , Burstr\u00f6m K , et al . EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2019;28:1951\u201361. doi:10.1007\/s11136-019-02115-x","key":"2025120803001968000_15.6.e102509.34","DOI":"10.1007\/s11136-019-02115-x"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.35","DOI":"10.1097\/00005650-200108000-00006"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.36","DOI":"10.1002\/cncr.10428"},{"unstructured":"EuroQol Research Foundation . EQ-5D-5L user guide, 2019. Available: https:\/\/euroqol.org\/publications\/user-guides","key":"2025120803001968000_15.6.e102509.37"},{"key":"2025120803001968000_15.6.e102509.38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jval.2022.01.009","article-title":"The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results","volume":"25","author":"Brazier","year":"2022","journal-title":"Value Health"},{"key":"2025120803001968000_15.6.e102509.39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40273-025-01473-4","article-title":"EQ-5D-5L or EQ-HWB-S: Which is the Better Instrument for Capturing Spillover Effects in Parental Carers of Children with COVID-19?","volume":"43","author":"Zhou","year":"2025","journal-title":"Pharmacoeconomics"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.40","DOI":"10.2307\/2955359"},{"key":"2025120803001968000_15.6.e102509.41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00586-017-5330-1","article-title":"Responsiveness of the EuroQoL 5-dimension (EQ-5D) in adolescent idiopathic scoliosis","volume":"27","author":"Cheung","year":"2018","journal-title":"Eur Spine J"},{"key":"2025120803001968000_15.6.e102509.42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10198-024-01669-z","article-title":"Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers","volume":"25","author":"Zhou","year":"2024","journal-title":"Eur J Health Econ"},{"key":"2025120803001968000_15.6.e102509.43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijnurstu.2017.11.003","article-title":"Evaluating test-retest reliability in patient-reported outcome measures for older people: A systematic review","volume":"79","author":"Park","year":"2018","journal-title":"Int J Nurs Stud"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.44","DOI":"10.1093\/intqhc\/mzm042"},{"unstructured":"Cohen J . Statistical power analysis for behavioral science (Lawrence Earlbaum Associates, Hilsdale). 2nd edn. 1988.","key":"2025120803001968000_15.6.e102509.45"},{"key":"2025120803001968000_15.6.e102509.46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1348\/000711006X126600","article-title":"Computing inter\u2010rater reliability and its variance in the presence of high agreement","volume":"61","author":"Gwet","year":"2008","journal-title":"Brit J Math & Statis"},{"doi-asserted-by":"publisher","key":"2025120803001968000_15.6.e102509.47","DOI":"10.1191\/1478088706qp063oa"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-102509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T11:00:33Z","timestamp":1765191633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-102509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,18]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2025-102509"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-102509","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}